Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 22

    1.

    Adipocytes impair leukemia treatment in mice.

    Behan JW, Yun JP, Proektor MP, Ehsanipour EA, Arutyunyan A, Moses AS, Avramis VI, Louie SG, Butturini A, Heisterkamp N, Mittelman SD.

    Cancer Res. 2009 Oct 1;69(19):7867-74. Epub 2009 Sep 22.PMID: 19773440 [PubMed - in process]Related articles

    2.

    Reciprocal relations of subcutaneous and visceral fat to bone structure and strength.

    Gilsanz V, Chalfant J, Mo AO, Lee DC, Dorey FJ, Mittelman SD.

    J Clin Endocrinol Metab. 2009 Sep;94(9):3387-93. Epub 2009 Jun 16.PMID: 19531595 [PubMed - indexed for MEDLINE]Related articles

    3.

    Differential effect of marrow adiposity and visceral and subcutaneous fat on cardiovascular risk in young, healthy adults.

    Di Iorgi N, Mittelman SD, Gilsanz V.

    Int J Obes (Lond). 2008 Dec;32(12):1854-60. Epub 2008 Oct 7.PMID: 18838978 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Reciprocal relation between marrow adiposity and the amount of bone in the axial and appendicular skeleton of young adults.

    Di Iorgi N, Rosol M, Mittelman SD, Gilsanz V.

    J Clin Endocrinol Metab. 2008 Jun;93(6):2281-6. Epub 2008 Apr 1.PMID: 18381577 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Relationship of highly sensitive C-reactive protein and lipid levels in adolescents with type 1 diabetes mellitus.

    Karantza MV, Mittelman SD, Dorey F, Samie S, Kaiserman K, Halvorson M, Kaufman FR.

    Pediatr Diabetes. 2008 Apr;9(2):122-6. Epub 2007 Nov 23.PMID: 18036131 [PubMed - indexed for MEDLINE]Related articles

    6.

    Fat mass is not beneficial to bone in adolescents and young adults.

    Janicka A, Wren TA, Sanchez MM, Dorey F, Kim PS, Mittelman SD, Gilsanz V.

    J Clin Endocrinol Metab. 2007 Jan;92(1):143-7. Epub 2006 Oct 17.PMID: 17047019 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    A hypocalcemic child with a novel activating mutation of the calcium-sensing receptor gene: successful treatment with recombinant human parathyroid hormone.

    Mittelman SD, Hendy GN, Fefferman RA, Canaff L, Mosesova I, Cole DE, Burkett L, Geffner ME.

    J Clin Endocrinol Metab. 2006 Jul;91(7):2474-9. Epub 2006 Apr 11.PMID: 16608894 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Obesity and fat quantification in lean tissues using three-point Dixon MR imaging.

    Kovanlikaya A, Mittelman SD, Ward A, Geffner ME, Dorey F, Gilsanz V.

    Pediatr Radiol. 2005 Jun;35(6):601-7. Epub 2005 Mar 23.PMID: 15785930 [PubMed - indexed for MEDLINE]Related articles

    9.

    Elevated glucagon-like peptide-1-(7-36)-amide, but not glucose, associated with hyperinsulinemic compensation for fat feeding.

    van Citters GW, Kabir M, Kim SP, Mittelman SD, Dea MK, Brubaker PL, Bergman RN.

    J Clin Endocrinol Metab. 2002 Nov;87(11):5191-8.PMID: 12414891 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Extreme insulin resistance of the central adipose depot in vivo.

    Mittelman SD, Van Citters GW, Kirkman EL, Bergman RN.

    Diabetes. 2002 Mar;51(3):755-61.PMID: 11872676 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Lack of hepatic "interregulation" during inhibition of glycogenolysis in a canine model.

    Fosgerau K, Mittelman SD, Sunehag A, Dea MK, Lundgren K, Bergman RN.

    Am J Physiol Endocrinol Metab. 2001 Aug;281(2):E375-83.PMID: 11440915 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Central role of the adipocyte in the metabolic syndrome.

    Bergman RN, Van Citters GW, Mittelman SD, Dea MK, Hamilton-Wessler M, Kim SP, Ellmerer M.

    J Investig Med. 2001 Jan;49(1):119-26. Review.PMID: 11217141 [PubMed - indexed for MEDLINE]Related articles

    13.

    Longitudinal compensation for fat-induced insulin resistance includes reduced insulin clearance and enhanced beta-cell response.

    Mittelman SD, Van Citters GW, Kim SP, Davis DA, Dea MK, Hamilton-Wessler M, Bergman RN.

    Diabetes. 2000 Dec;49(12):2116-25.PMID: 11118015 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Paradoxical effect of troglitazone in normal animals: enhancement of adipocyte but reduction of liver insulin sensitivity.

    Dea MK, Van Citters GW, Ader M, Mittelman SD, Sunehag AL, Bergman RN.

    Diabetes. 2000 Dec;49(12):2087-93.PMID: 11118011 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Inhibition of lipolysis causes suppression of endogenous glucose production independent of changes in insulin.

    Mittelman SD, Bergman RN.

    Am J Physiol Endocrinol Metab. 2000 Sep;279(3):E630-7.PMID: 10950832 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Rapid oscillations in omental lipolysis are independent of changing insulin levels in vivo.

    Getty L, Panteleon AE, Mittelman SD, Dea MK, Bergman RN.

    J Clin Invest. 2000 Aug;106(3):421-30.PMID: 10930445 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes.

    Carpentier A, Mittelman SD, Bergman RN, Giacca A, Lewis GF.

    Diabetes. 2000 Mar;49(3):399-408.PMID: 10868961 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation.

    Carpentier A, Mittelman SD, Lamarche B, Bergman RN, Giacca A, Lewis GF.

    Am J Physiol. 1999 Jun;276(6 Pt 1):E1055-66.PMID: 10362618 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Central role of the adipocyte in insulin resistance.

    Bergman RN, Mittelman SD.

    J Basic Clin Physiol Pharmacol. 1998;9(2-4):205-21. Review.PMID: 10212835 [PubMed - indexed for MEDLINE]Related articles

    20.

    Role of portal insulin delivery in the disappearance of intravenous glucose and assessment of insulin sensitivity.

    Steil GM, Rebrin K, Mittelman SD, Bergman RN.

    Diabetes. 1998 May;47(5):714-20.PMID: 9588441 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Indirect effect of insulin to suppress endogenous glucose production is dominant, even with hyperglucagonemia.

    Mittelman SD, Fu YY, Rebrin K, Steil G, Bergman RN.

    J Clin Invest. 1997 Dec 15;100(12):3121-30.PMID: 9399959 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs.

    Rebrin K, Steil GM, Mittelman SD, Bergman RN.

    J Clin Invest. 1996 Aug 1;98(3):741-9.PMID: 8698866 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...